CVS Health Long-Term Debt decreased by 0.7% to $65.84B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $65.53B to $65.84B. Over 4 years (FY 2020 to FY 2024), Long-Term Debt shows relatively stable performance with a 0.6% CAGR.
An increase indicates higher financial leverage, which can amplify returns on equity but also increases interest expense and financial risk.
Loans and financial obligations with a maturity period exceeding one year, typically consisting of corporate bonds and n...
Capital-intensive firms or those with aggressive share buyback programs often carry higher long-term debt than asset-light competitors.
long_term_debt| Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.39B | $56.18B | $54.82B | $52.21B | $52.26B | $58.23B | $63.82B | $61.91B | $61.61B | $66.37B | $65.53B | $66.27B | $65.84B |
| QoQ Change | — | -3.8% | -2.4% | -4.7% | +0.1% | +11.4% | +9.6% | -3.0% | -0.5% | +7.7% | -1.3% | +1.1% | -0.7% |
| YoY Change | — | — | — | -10.6% | -7.0% | — | +16.4% | +18.6% | +17.9% | +4.0% | +5.8% | +7.6% | +0.5% |